-
VE-821 ATR Kinase Inhibitor Workflow
2026-09-03
VE-821 is a selective ATR kinase inhibitor for connecting checkpoint biology with radiosensitization, chemotherapy sensitization, and DNA repair pathway research. This workflow also provides a carefully bounded way to test whether ATR signaling influences the DNMT1-dependent replication and RNA-processing phenotypes reported for human bocavirus 1.
-
MK 0893: Discovery of a Glucagon Receptor Antagonist
2026-09-03
The reference study describes the medicinal chemistry optimization and preclinical validation of MK 0893, a potent, reversible, and competitive glucagon receptor antagonist. Its nanomolar activity, receptor selectivity, oral in vivo efficacy, and glucose-lowering effects established a rationale for advancing this scaffold in type 2 diabetes research.
-
Linezolid as a Translational Assay Benchmark
2026-09-02
Linezolid is an oxazolidinone antimicrobial and a useful benchmark for connecting ribosome-proximal assays with whole-cell antibacterial evidence. This article explains how to use it rigorously alongside the MmpL3-focused tuberculosis discovery study without confusing distinct mechanisms or endpoints.
-
Live-Dead Cell Staining Kit I for Ferroptosis
2026-09-02
Use dual Calcein AM/PI fluorescence to distinguish viable mammalian cells from membrane-compromised cells during drug, biomaterial, and cancer experiments. This practical workflow shows how the assay can complement ferroptosis-focused studies without mistaking a live/dead readout for a mechanism-specific endpoint.
-
Staurosporine in Assay-Ready Cell Models
2026-09-01
Staurosporine is a broad-spectrum serine/threonine protein kinase inhibitor with powerful applications in apoptosis, angiogenesis, and cancer research. This guide adds a practical perspective by showing how post-thaw cell state and cryopreservation quality can shape kinase-inhibitor assay interpretation.
-
Streptavidin-Cy3 for Biotin Detection
2026-09-01
Streptavidin-Cy3 is a fluorescent streptavidin conjugate for visualizing biotinylated antibodies, proteins, nucleic acids, and other biomolecules. Its four-site biotin-binding tetramer and nominal 554 nm excitation and 568 nm emission maxima support IHC, IF, ISH, ICC, and flow cytometry workflows when storage and spectral controls are maintained.
-
Cannabidiol in Orofacial Inflammatory Pain
2026-08-31
This 2026 study shows that cannabidiol (CBD) can reduce both inflammatory nociception and pain-related affective deficits in mice through coordinated peripheral, central, and serotonergic mechanisms. Its multimodal design links behavioral outcomes with molecular assays and fiber photometry, providing a useful framework for evaluating therapies that address sensory pain together with anxiety, depressive-like behavior, and cognitive impairment.
-
Alternariol, LX-2 Cells, and Liver Fibrosis
2026-08-31
The reference study shows that Alternariol (AOH) and alternariol monomethyl ether can convert LX-2 hepatic stellate cells toward a contractile, extracellular-matrix-producing myofibroblast phenotype, whereas tenuazonic acid produced no significant response under the tested conditions. By combining lncRNA-mRNA omics with phenotypic and pathway analyses, the work connects emerging Alternaria toxins with NF-κB activation, ferroptosis, autophagy-related signaling, and a CotA laccase-based detoxification strategy.
-
U0126: MEK1/2 Inhibitor Workflow Guide
2026-08-30
U0126 provides a cell-permeable, non-ATP-competitive route to test whether MEK1/2 controls ERK-dependent phenotypes. This practical guide connects Raf/MEK/ERK pathway blockade with tau pathology, cancer biology research, and autophagy assays while emphasizing controls, timing, and troubleshooting.
-
CD38 CAR Binders: Structure-Guided Affinity Tuning
2026-08-28
Cheng and colleagues define how the CD38-targeting CAR binders RP02 and 028 recognize distinct antigen surfaces and alter CD38 enzymatic function. Their structure-guided analysis shows that affinity attenuation of 028 can reduce CAR-T fratricide while preserving antitumor cytotoxicity, providing a mechanistic framework for safer CD38-directed therapy.
-
Bacitracin (B1670): Practical Research Protocol
2026-08-28
Bacitracin (B1670) is a solid peptide antibiotic for controlled antibacterial research involving bacterial cell wall and peptidoglycan synthesis. This guide covers solvent selection, storage, assay controls, and troubleshooting; the material is for scientific research only and must not be used for diagnostic or medical purposes.
-
7-AAD Cell Viability Assay Kit for CAR-T Studies
2026-08-27
The 7-AAD Cell Viability Assay Kit provides a practical way to quantify membrane-compromised cells during CD38 CAR-T development while preserving multiplex compatibility with FITC, PE, and APC markers. This guide connects structural affinity tuning with reproducible flow cytometry viability assay and fluorescence microscopy cell viability workflows.
-
PPM-18: NF-κB/iNOS Assay Guide
2026-08-27
A scenario-based guide to using PPM-18 (N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide), SKU C4074, in viability, inflammatory, and cytotoxicity workflows. It explains mechanism, DMSO handling, dose optimization, interpretation of nitrite and iNOS endpoints, and practical supplier-selection criteria.
-
Live-Dead Cell Staining Kit I: Assay Logic
2026-08-26
The Live-Dead Cell Staining Kit I transforms Calcein AM/PI staining into a decision-oriented mammalian cell viability assay. Learn how to interpret membrane integrity, distinguish phenotype from mechanism, and strengthen ferroptosis-related cytotoxicity studies in TNBC models.
-
SU 5402: From RTK Biology to Translational Models
2026-08-26
SU 5402 offers a mechanistically useful way to interrogate VEGFR2, FGFR1, PDGFRβ, and EGFR signaling while connecting cancer biology workflows with emerging human sensory-neuron models. This article outlines evidence, experimental design, translational boundaries, and opportunities for disciplined cross-domain research.